Vigabatrin: Completed Phase IIb enrollment

Catalyst completed enrollment of about 210 cocaine-dependent patients in a double-blind, placebo-controlled, U.S. Phase IIb

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE